University of Maryland Researchers Develop Smart Underwear to Measure Human Flatulence
By
ohjeez
Kettled twice. Extra chewy, extra trustworthy.
Summary
University of Maryland scientists have developed 'Smart Underwear,' a wearable device that measures human flatulence by tracking hydrogen in flatus. The device aims to provide accurate data on how often people actually fart, challenging long-standing assumptions, and offers new insights into gut microbial metabolism. The research is part of a nationwide study recruiting volunteers to map the full spectrum of human flatulence, with potential applications for helping patients with intestinal issues.
Key quotes
· 4 pulledScientists at the University of Maryland have created Smart Underwear, the first wearable device designed to measure human flatulence.
By tracking hydrogen in flatus, the device helps scientists revisit long-standing assumptions about how often people actually fart.
It also opens a new window into measuring gut microbial metabolism in everyday life.
A new nationwide study is recruiting volunteers to map the full spectrum of human flatulence.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
